NCT02432040View on ClinicalTrials.gov

Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Psoriasis
Interventions
DRUG

Atorvastatin

Atorvastatin is a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor used to treat dyslipidemia

DRUG

Placebo

Placebo tablets, made to look like the interventional drug

Trial Locations (1)

1000

University of the Philippines - Philippine General Hospital Section of Dermatology, Manila

All Listed Sponsors
lead

Philippine Dermatological Society

NETWORK

NCT02432040 - Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis | Biotech Hunter | Biotech Hunter